Neurotech International Statistics
Want to see AU:NTI full AI Analyst Report?
Neurotech International (NTI) Stock Statistics & Valuation Metrics
Total Valuation
Neurotech International has a market cap or net worth of AUD 32.32M. The enterprise value is AUD 16.06M.
- Market Cap
- AUD 32.32M
- Enterprise Value
- AUD 16.06M
Share Statistics
Neurotech International has 1,616,070,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,616,070,000
- Owned by Insiders
- 10.80%
- Owned by Institutions
- ―
Financial Efficiency
Neurotech International’s return on equity (ROE) is -10.70 and return on invested capital (ROIC) is -1075.52%.
- Return on Equity (ROE)
- -10.70
- Return on Assets (ROA)
- -2.38
- Return on Invested Capital (ROIC)
- -1075.52%
- Return on Capital Employed (ROCE)
- -18.54
- Revenue Per Employee
- 0
- Profits Per Employee
- -363.25K
- Employee Count
- 18
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Neurotech International is -4.77. Neurotech International’s PEG ratio is 0.54.
- PE Ratio
- -4.77
- PS Ratio
- 0.00
- PB Ratio
- 45.28
- Price to FCF
- -8.03
- Price to Operating Cash Flow
- -6.55
- PEG Ratio
- 0.54
Income Statement
In the last 12 months, Neurotech International had revenue of 0 and earned -6.54M in profits. Earnings per share was -0.01.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -11.33M
- Pretax Income
- -11.27M
- Net Income
- -6.54M
- EBITDA
- -11.33M
- Earnings Per Share (EPS)
- -0.01
Cash Flow
In the last 12 months, operating cash flow was -4.22M and capital expenditures -4, giving a free cash flow of -4.22M billion.
- Operating Cash Flow
- -4.22M
- Free Cash Flow
- -4.22M
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Neurotech International pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -13.07%
- Earnings Yield
- -24.81%
Stock Price Statistics
- Beta
- 0.99
- 52-Week Price Change
- 25.00%
- 50-Day Moving Average
- 0.01
- 200-Day Moving Average
- 0.01
- Relative Strength Index (RSI)
- 71.10
- Average Volume (3m)
- 4.48M
Important Dates
Neurotech International upcoming earnings date is Mar 02, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Sep 02, 2026
- Next Earnings Date
- Mar 02, 2027
- Ex-Dividend Date
- ―
Financial Position
Neurotech International as a current ratio of 1.29, with Debt / Equity ratio of 0.00%
- Current Ratio
- 1.29
- Quick Ratio
- 1.29
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.21
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Neurotech International has paid -4.73M in taxes.
- Income Tax
- -4.73M
- Effective Tax Rate
- 0.42
Enterprise Valuation
Neurotech International EV to EBITDA ratio is -2.64, with an EV/FCF ratio of -7.09.
- EV to Sales
- 0.00
- EV to EBITDA
- -2.64
- EV to Free Cash Flow
- -7.09
- EV to Operating Cash Flow
- -7.09
Balance Sheet
Neurotech International has AUD 2.39M in cash and marketable securities with AUD 0.00 in debt, giving a net cash position of AUD 2.39M billion.
- Cash & Marketable Securities
- AUD 2.39M
- Total Debt
- AUD 0.00
- Net Cash
- AUD 2.39M
- Net Cash Per Share
- AUD 0.00
- Tangible Book Value Per Share
- AUD 0.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Neurotech International is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -100.00%
- EPS Growth Forecast
- 50.49%
Scores
- Smart Score
- 7
- AI Score
- 47

